Skip to main content

BION ENVIRONMENTAL TECHNOLOGIES INC

For the period ended Mar 31, 2025. Filed May 15, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 15, 2025

BNETStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Statement of changes in equity (deficit)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

THREE AND NINE MONTHS ENDED MARCH 31, 2025 AND 2024

Three months ended March 31, 2025 and 2024

Bion's Stockholders'
Series A Preferred Stock · Series C Preferred Stock · Common Stock · Additional paid-in · Subscription Receivables for · Accumulated · Noncontrolling · Total
SharesAmountSharesAmountSharesAmountcapitalSharesdeficitinterestequity/(deficit)
Balances, December 31, 2023—$——$—50,611,962$—$132,798,923$(504,650)$(128,700,799)$37,573$3,631,047
Sale of units————190,000—190,000———190,000
Warrants exercised under cashless exercise————5,866,306——————
Options exercised under cashless exercise————3,661——————
Issuance of warrants for services————25,770—30,000———30,000
Vesting of options for employees and services——————52,378———52,378
Vesting of warrants for employees and services——————3,281———3,281
Debt modification——————(11,122)———(11,122)
Conversion of debt and liabilities————522,231—49,403———49,403
Commission on the sales of units——————(14,400)———(14,400)
Net Loss————————(538,145)—(538,145)
Balances, March 31, 2024—$——$—57,219,930$—$133,098,463$(504,650)$(129,238,944)$37,573$3,392,442
Balances, December 31, 2024—$——$—57,236,479$—$134,469,460$(504,650)$(140,473,767)$37,573$(6,471,384)
Issuance of shares for services————149,997—28,500———28,500
Modification of warrants——————178,684———178,684
Commission on the sales of units——————(5,300)———(5,300)
Net loss————————(511,156)—(511,156)
Balances, March 31, 2025—$——$—57,386,476$—$134,671,344$(504,650)$(140,984,923)$37,573$(6,780,656)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

THREE AND NINE MONTHS ENDED MARCH 31, 2025 AND 2024

(CONTINUED)

Nine months ended March 31, 2025 and 2024

Bion's Stockholders'
Series A Preferred Stock · Series C Preferred Stock · Common Stock · Additional paid-in · Subscription Receivables for · Accumulated · Noncontrolling · Total
SharesAmountSharesAmountSharesAmountcapitalSharesdeficitinterestequity/(deficit)
Balances, July 1, 2023—$——$—48,880,237$—131,935,418$(504,650)$(127,236,663)$37,573$4,231,678
Sale of units————593,589—610,742———610,742
Warrants exercised for common shares————38,000—28,500———28,500
Warrants exercised under cashless exercise————6,131,945——————
Options exercised under cashless exercise————3,661——————
Issuance of units for services————82,529—76,320———76,320
Issuance of warrants for services——————35,000———35,000
Vesting of options for employees and services——————159,865———159,865
Vesting of warrants for employees and services——————9,844———9,844
Debt modification——————(27,983)———(27,983)
Conversion of debt and liabilities————1,489,969—140,951———140,951
Modification of warrants——————150,206———150,206
Commission on sale of units——————(20,400)———(20,400)
Net loss————————(2,002,281)—(2,002,281)
Balances, March 31, 2024—$——$—57,219,930$—$133,098,463$(504,650)$(129,238,944)$37,573$3,392,442
Balances, July 1, 2024—$——$—57,227,248$—133,623,927$(504,650)$(138,927,778)$37,573$(5,770,928)
Issuance of units for services————159,228—34,500———34,500
Modification of warrants——————686,089———686,089
Modification of options——————332,128———332,128
Commission on the sales of units——————(5,300)———(5,300)
Net loss————————(2,057,145)—(2,057,145)
Balances, March 31, 2025—$——$—57,386,476$—$134,671,344$(504,650)$(140,984,923)$37,573$(6,780,656)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.